Forkhead box proteins: tuning forks for transcriptional harmony.
The DOI matches its Crossref record; 198 of the 199 references it cites were found in a registry or an index.
Abstract
Forkhead box (FOX) proteins are multifaceted transcription factors that are responsible for fine-tuning the spatial and temporal expression of a broad range of genes both during development and in adult tissues. This function is engrained in their ability to integrate a multitude of cellular and environmental signals and to act with remarkable fidelity. Several key members of the FOXA, FOXC, FOXM, FOXO and FOXP subfamilies are strongly implicated in cancer, driving initiation, maintenance, progression and drug resistance. The functional complexities of FOX proteins are coming to light and have established these transcription factors as possible therapeutic targets and putative biomarkers for specific cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been suggested that crosstalk between RB and mitogenic AKT signaling pathways play a key role in the quiescence to senescence switch by regulating overlapping functions of Forkhead transcription factors, FOXO3a and FOXM1 (Eijkelenboom and Burgering, 2013; Lam et al., 2013; Imai et al., 2014).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Lam et al., 2013
Citations
Cites
2 retracted
Wang, Z., Banerjee, S., Kong, D., Li, Y., & Sarkar, F. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1265 · Cited by 245
RetractedBao, B., Wang, Z., Ali, S., Kong, D., Banerjee, S., Ahmad, A., Li, Y., Azmi, A. S., Miele, L., & Sarkar, F. H. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23150 · Cited by 206
RetractedComprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R., Dunning, M. J., Brown, G. D., Gojis, O., Ellis, I. O., Green, A. R., et al. (2012) · Nature · doi:10.1038/nature10730 · Cited by 2,173
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1799 · Cited by 1,639
Pioneer transcription factors: establishing competence for gene expression
Zaret, K. S., & Carroll, J. S. (2011) · Genes & Development · doi:10.1101/gad.176826.111 · Cited by 1,589
Cited by
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
Cyclic Decidualization of the Human Endometrium in Reproductive Health and Failure
Gellersen, B., & Brosens, J. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1045 · Cited by 1,139
Self-citationAMPK–SKP2–CARM1 signalling cascade in transcriptional regulation of autophagy
Shin, H.-J. R., Kim, H., Oh, S., Lee, J.-G., Kee, M., Ko, H.-J., Kweon, M.-N., Won, K.-J., & Baek, S. H. (2016) · Nature · doi:10.1038/nature18014 · Cited by 417
FOXO transcription factor family in cancer and metastasis
Jiramongkol, Y., & Lam, E. W.-F. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09883-w · Cited by 281
“FOXOs are considered to be tumour suppressors by virtue of their established functions in cell cycle arrest, senescence, apoptosis, differentiation, DNA damage repair and scavenging of reactive oxygen species [2].”
BackgroundInfluentialSelf-citationPROTACs: great opportunities for academia and industry (an update from 2020 to 2021)
He, M., Cao, C., Ni, Z., Liu, Y., Song, P., Hao, S., He, Y., Sun, X., & Rao, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00999-9 · Cited by 283
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
Rochette, L., Guenancia, C., Gudjoncik, A., Hachet, O., Zeller, M., Cottin, Y., & Vergely, C. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.005 · Cited by 248
Khongkow, P., Gomes, A. R., Gong, C., Man, E. P. S., Tsang, J. W.-H., Zhao, F., Monteiro, L. J., Coombes, R. C., Medema, R. H., Khoo, U. S., et al. (2016) · Oncogene · doi:10.1038/onc.2015.152 · Cited by 233
Self-citationYu, J.-M., Sun, W., Wang, Z.-H., Liang, X., Hua, F., Li, K., Lv, X.-X., Zhang, X.-W., Liu, Y.-Y., Yu, J.-J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13700-6 · Cited by 228
The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
Yao, S., Fan, L. Y.-N., & Lam, E. W.-F. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.11.018 · Cited by 223
“Most crucially, FOXO3 is negatively regulated by phosphatidylinositol 3-kinase (PI3K)-Akt/Protein Kinase B (PKB) and Ras-Raf-MEKextracellular signal-regulated kinase (ERK) signalling pathways in reponse to a variety of external stimuli and growth factors [2,8,9].”
BackgroundInfluentialSelf-citationFOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance
Zona, S., Bella, L., Burton, M. J., Nestal de Moraes, G., & Lam, E. W.-F. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.09.016 · Cited by 225
Self-citationDownregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis
Liu, H., Song, Y., Qiu, H., Liu, Y., Luo, K., Yi, Y., Jiang, G., Lu, M., Zhang, Z., Yin, J., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0389-3 · Cited by 221
Calvert, A. E., Chalastanis, A., Wu, Y., Hurley, L. A., Kouri, F. M., Bi, Y., Kachman, M., May, J. L., Bartom, E., Hua, Y., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.014 · Cited by 204
“As Akt-mediated phosphorylation inhibits FoxO transcriptional functions (Lam et al., 2013), we examined whether RTK inhibition and its downstream effect on suppressing Akt activity increased IDH1 transcript and protein levels through FoxO activation.”
BackgroundZhao, S., Ma, D., Xiao, Y., Li, X.-M., Ma, J.-L., Zhang, H., Xu, X.-L., Lv, H., Jiang, W.-H., Yang, W.-T., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2019-0982 · Cited by 197
“FOXC1, a member of the forkhead box family, regulates several biological processes, including cell growth, proliferation, differentiation, migration, and survival [45, 46].”
BackgroundSaito, Y., Chikenji, T. S., Matsumura, T., Nakano, M., & Fujimiya, M. (2020) · Nature Communications · doi:10.1038/s41467-020-14734-x · Cited by 196
Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1
Hasegawa, T., Kikuta, J., Sudo, T., Matsuura, Y., Matsui, T., Simmons, S., Ebina, K., Hirao, M., Okuzaki, D., Yoshida, Y., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0526-7 · Cited by 188
FOXC1: an emerging marker and therapeutic target for cancer
Han, B., Bhowmick, N., Qu, Y., Chung, S., Giuliano, A. E., & Cui, X. (2017) · Oncogene · doi:10.1038/onc.2017.48 · Cited by 175
Foxp3 Post-translational Modifications and Treg Suppressive Activity
Deng, G., Song, X., Fujimoto, S., Piccirillo, C. A., Nagai, Y., & Greene, M. I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02486 · Cited by 162
FOXM1: A key oncofoetal transcription factor in health and disease
Bella, L., Zona, S., Nestal de Moraes, G., & Lam, E. W.-F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.07.008 · Cited by 171
Self-citationTranscriptional control of chondrocyte specification and differentiation
Liu, C.-F., Samsa, W. E., Zhou, G., & Lefebvre, V. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2016.10.004 · Cited by 165
“These proteins are categorized into 19 groups (FOXA to FOXS) and several are known to achieve pivotal pioneer, transactivation and transrepression functions in major processes, including skeletogenesis [121, 122].”
The Genetic and Mechanistic Basis for Variation in Gene Regulation
Pai, A. A., Pritchard, J. K., & Gilad, Y. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004857 · Cited by 164
“Chromatin areas that are accessible because of pioneer activity are available for binding by secondary factors [57,58].”
BackgroundOncogenic regulation of tumor metabolic reprogramming
Tarrado-Castellarnau, M., de Atauri, P., & Cascante, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10911 · Cited by 161
“Post-translational modifications such as phosphorylation, acetylation and ubiquitination regulate the translocation of FOXO proteins to the nucleus [196] where they activate transcription by binding to gene regulatory regions [197].”
BackgroundInfluentialCánovas, Á., Reverter, A., DeAtley, K. L., Ashley, R. L., Colgrave, M. L., Fortes, M. R. S., Islas‐Trejo, A., Lehnert, S. A., Porto-Neto, L. R., Rincón, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102551 · Cited by 179
“These TF are involved in a variety of biological processes such as body development and metabolism [68,69].”
BackgroundFOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression
Hu, G., Yan, Z., Zhang, C., Cheng, M., Yan, Y., Wang, Y., Deng, L., Lu, Q., & Luo, S. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1202-3 · Cited by 161
Proteomic analyses reveal distinct chromatin‐associated and soluble transcription factor complexes
Li, X., Wang, W., Wang, J., Malovannaya, A., Xi, Y., Li, W., Guerra, R., Hawke, D. H., Qin, J., & Chen, J. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145504 · Cited by 152
“FOX family TFs play important roles in regulating the expression of genes involved in a sundry of cellular processes, especially during development and tumorigenesis (Benayoun et al, 2011; Lam et al, 2013).”
BackgroundPullamsetti, S. S., Savai, R., Seeger, W., & Goncharova, E. A. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201606-1226pp · Cited by 158
Franco, H. L., Nagari, A., Malladi, V. S., Li, W., Xi, Y., Richardson, D., Allton, K. L., Tanaka, K., Li, J., Murakami, S., et al. (2018) · Genome Research · doi:10.1101/gr.226019.117 · Cited by 159
“The Forkhead (FOX) proteins comprise a diverse family of TFs with roles in a variety of biological systems, including cancers (Benayoun et al. 2011; Lam et al. 2013).”
Laissue, P. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0938-x · Cited by 149
“CIMP: CpG island methylator phenotype; CIN: Chromosomal instability; CRC: Colorectal cancer; DBD: DNA binding domain; FKH: Forkhead; FOX: The forkhead box; FOX-DBD: Forkhead domain; MSI: Microsatellite instability; NES: Nuclear export sequence; NLS: Nuclear localisation sequence; NRD: Negative-regulatory domain; TAD:…”
BackgroundInfluentialAmin, A. R. M. R., Karpowicz, P. A., Carey, T. E., Arbiser, J. L., Nahta, R., Chen, Z. G., Dong, J., Küçük, Ö., Khan, G. N., Huang, G. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.005 · Cited by 166
“FOXO proteins are well characterized tumor suppressors: simultaneous somatic deletions of FOXO1, 3 and 4 alleles generates thymic lymphomas and systemic hemagiomas in mice (reviewed in [39]).”
BackgroundInfluentialMayne, B. T., Bianco-Miotto, T., Buckberry, S., Breen, J., Clifton, V., Shoubridge, C., & Roberts, C. T. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00183 · Cited by 140
“UCSC.hg19.knownGene: Annotation package for TxDb object(s).”
BackgroundDiscovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical Modeling
Flobak, Å., Baudot, A., Rémy, É., Thommesen, L., Thieffry, D., Kuiper, M. T. R., & Lægreid, A. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004426 · Cited by 145
“The model-based suggestion that FOXO activation may be important for synergistic growth inhibition does find experimental support in numerous accounts of FOXO proteins acting as mediators of cytotoxic chemotherapeutic drugs [39].”
BackgroundAutophagy protects chondrocytes from glucocorticoids-induced apoptosis via ROS/Akt/FOXO3 signaling
Shen, C., Cai, G., Peng, J., & Chen, X. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.06.020 · Cited by 134
FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance
Khongkow, P., Karunarathna, U., Khongkow, M., Gong, C., Gomes, A., Yagüe, E., Monteiro, L. J., Kongsema, M., Zona, S., Man, E. P. S., et al. (2013) · Oncogene · doi:10.1038/onc.2013.457 · Cited by 142
“FOXM1 is a member of the Forkhead box (FOX) superfamily of transcription factors that share a conserved winged-helix DNA-binding domain (14).”
BackgroundSelf-citationHuman FOXP3 and tumour microenvironment
Wang, J., Gong, R., Zhao, C., Lei, K., Sun, X., & Ren, H. (2022) · Immunology · doi:10.1111/imm.13520 · Cited by 131
“FOXP3 belongs to the family of forkhead transcription factors and is mainly localized in the nucleus [1, 2].”
BackgroundUncovering pseudotemporal trajectories with covariates from single cell and bulk expression data
Campbell, K. R., & Yau, C. (2018) · Nature Communications · doi:10.1038/s41467-018-04696-6 · Cited by 148
Kundu, S. T., Byers, L. A., Peng, D. H., Roybal, J. D., Diao, L., Wang, J., Tong, P., Creighton, C. J., & Gibbons, D. L. (2016) · Oncogene · doi:10.1038/onc.2015.71 · Cited by 125
The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
Hou, Y., Zhu, Q., Li, Z., Peng, Y., Yu, X., Yuan, B., Liu, Y., Liu, Y., Yin, L., Peng, Y., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.53 · Cited by 120
“FOXM1 is a cell growth-specific transcription factor that regulates the transcription of cell cycle regulatory genes, which are closely associated with G1/S and G2/M transitions.(19) Recent wholegenome studies suggested that abcc5 may be a target gene regulated by FOXM1, as ChIP-seq data showed a very strong binding p…”
BackgroundFOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance
de Moraes, G. N., Delbue, D., Silva, K. L., Robaina, M. C., Khongkow, P., Gomes, A., Zona, S., Crocamo, S., Mencalha, A. L., Magalhães, L. M., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.09.013 · Cited by 123
Self-citationFoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis
Al-tamari, H. M., Dabral, S., Schmall, A., Sarvari, P., Ruppert, C., Paik, J., DePinho, R. A., Grimminger, F., Eickelberg, O., Günther, A., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606261 · Cited by 130
“In mammals, four FoxO isoforms have been identified: FoxO1, FoxO3, FoxO4, and FoxO6 (Lam et al, 2013).”
BackgroundJing, J., Feng, J., Yuan, Y., Guo, T., Lei, J., Pei, F., Ho, T., & Chai, Y. (2022) · Nature Communications · doi:10.1038/s41467-022-32490-y · Cited by 124
Go, H., Jang, J.-Y., Kim, P.-J., Kim, Y. G., Nam, S. J., Paik, J. H., Kim, T. M., Heo, D. S., Kim, C.-W., & Jeon, Y. K. (2015) · Oncotarget · doi:10.18632/oncotarget.3729 · Cited by 119
“FOXO1 is a transcription factor for p27, p21, FasL, and Bim, which function as tumor suppressors by blocking the G1/S transition and inducing apoptosis [25-27].”
BackgroundFOXM1 is a critical driver of lung fibroblast activation and fibrogenesis
Penke, L. R. K., Speth, J. M., Dommeti, V. L., White, E. S., Bergin, I. L., & Peters-Golden, M. L. (2018) · Journal of Clinical Investigation · doi:10.1172/jci87631 · Cited by 126
Santos, B., Grenho, I., Martel, P. J., Ferreira, B. I., & Link, W. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06177-1 · Cited by 135
Vasquez, Y. M., Mazur, E. C., Li, X., Kommagani, R., Jiang, L., Chen, R., Lanz, R. B., Kovanci, E., Gibbons, W. E., & DeMayo, F. J. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1292 · Cited by 111
PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells
Naudin, C., Hattabi, A., Michelet, F., Miri-Nezhad, A., Benyoucef, A., Pflumio, F., Guillonneau, F., Fichelson, S., Vigon, I., Dusanter‐Fourt, I., et al. (2017) · Blood · doi:10.1182/blood-2016-10-747436 · Cited by 110
Krishnakumar, R., Chen, A. F., Pantovich, M. G., Danial, M., Parchem, R. J., Labosky, P. A., & Blelloch, R. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2015.10.003 · Cited by 112
“TF binding is regulated by DNA accessibility as determined by local chromatin structure.”
Chai, N., Xie, H., Yin, J., Sa, K.-D., Guo, Y., Wang, M., Liu, J., Zhang, X., Zhang, X., Yin, H., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.201 · Cited by 110
Luo, Q., Wang, C., Yang, L., Gao, X., Sun, H., Zhang, Y., Zhang, K.-L., Zhu, Y., Zheng, Y., Sheng, Y., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.12.021 · Cited by 105
Konopacki, C., Pritykin, Y., Rubtsov, Y., Leslie, C. S., & Rudensky, A. Y. (2019) · Nature Immunology · doi:10.1038/s41590-018-0291-z · Cited by 101
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
Liu, J., Duan, Z., Guo, W., Zeng, L., Wu, Y., Chen, Y., Tai, F., Wang, Y., Lin, Y., Zhang, Q., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07258-y · Cited by 106
MicroRNAs in Cardiac Hypertrophy
Wehbe, N., Nasser, S. A., Pintus, G., Badran, A., Eid, A. H., & Baydoun, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194714 · Cited by 105
“MiR-206 promoted Yes-associated protein (YAP)-induced cardiac hypertrophy by negatively regulating the expression of Forkhead box protein P1 [100], a transcription factor involved in cell cycle progression, proliferation, and differentiation, as well as in metabolism, survival, and apoptosis [101].”
BackgroundThe Dominant Role of Forkhead Box Proteins in Cancer
Bach, D., Long, N. P., Luu, T.-T.-T., Anh, N. H., Kwon, S. W., & Lee, S. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103279 · Cited by 106
“The forkhead box (FOX) family comprises diverse tissue- and cell type-specific transcription factors with a conserved winged-helix DNA-binding domain (DBD) or forkhead domain [1].”
BackgroundPal, S., Kozono, D., Yang, X., Fendler, W., Fitts, W., Ni, J., Alberta, J. A., Zhao, J., Liu, K. X., Bian, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3691 · Cited by 101
“Similar to our findings, decreased expression of FOXM1 was observed after treatment with trichostatin A, an HDAC inhibitor, and LY294002, a PI3K inhibitor (35,43,44).”
Gupta, S., Johnson, S. H., Vasmatzis, G., Porath, B., Rustin, J. G., Rao, P., Costello, B. A., Leibovich, B. C., Thompson, R. H., Cheville, J. C., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.24 · Cited by 104
Poppe, M., Wittig, S., Jurida, L., Bartkuhn, M., Wilhelm, J., Müller, H., Beuerlein, K., Karl, N., Bhuju, S., Ziebuhr, J., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006286 · Cited by 107
“These multifunctional proteins regulate transcriptional programs in cancer and innate immunity but their roles in RNA virus infection are unknown and await further investigation [57, 58].”
BackgroundLi, X., Wu, Q., Xie, Y., Ding, Y., Du, W. W., Sdiri, M., & Yang, B. B. (2015) · Oncotarget · doi:10.18632/oncotarget.4026 · Cited by 100
“It has been identified that the over-expression of Foxo3 inhibited tumor growth in vitro and tumor development in vivo in many cancer [49, 50].”
Resistance to Intervention: Paclitaxel in Breast Cancer
Dan, V. M., Raveendran, R. S., & Baby, S. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520999201214234421 · Cited by 105
FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer
Liu, C., Barger, C. J., & Karpf, A. R. (2021) · Cancers · doi:10.3390/cancers13123065 · Cited by 114
“FOXO3A suppresses FOXM1 activity via at least three mechanisms: (1) Downregulating FOXM1 gene expression, potentially through the upregulation of the Mad/Max family of transcriptional repressors [146–148]; (2) directly displacing FOXM1 from the promoter region of FOXM1 target genes [148–150]; and (3) condensing FOXM1…”
BackgroundGenetics of melanoma progression: the rise and fall of cell senescence
Bennett, D. C. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12422 · Cited by 85
“However, another major target of CDK4 is now known: CDK4 is also required to 128 ª 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd phosphorylate and activate the master G2/M transcription factor FOXM1 (Anders et al., 2011) (Figure 3), so that inhibition of CDK4 is also expected to arrest cells in G2, or…”
BackgroundInfluentialKamran, M., Long, Z.-J., Xu, D., Lv, S.-S., Liu, B., Wang, C.-L., Xu, J., Lam, E. W. ‐., & Liu, Q. (2017) · Oncogenesis · doi:10.1038/oncsis.2016.80 · Cited by 100
Self-citationForkhead box transcription factors in embryonic heart development and congenital heart disease
Zhu, H. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.12.001 · Cited by 93
Shen, H., Yu, X., Yang, F., Zhang, Z., Shen, J., Sun, J., Choksi, S., Jitkaew, S., & Shu, Y. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006244 · Cited by 91
“FOXO3a functions as a tumor suppressor gene mainly through triggering cell cycle arrest, repair of damaged DNA, and apoptosis [43, 44].”
BackgroundXia, P., Chen, J., Liu, Y., Fletcher, M., Jensen, B. C., & Cheng, Z. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011571 · Cited by 89
“1) was associated with up-regulation of Bim (8), a FOXO1 target gene (22).”
BackgroundGhosh, S., Singh, R., Vanwinkle, Z. M., Guo, H., Vemula, P. K., Goel, A., Haribabu, B., & Jala, V. R. (2022) · Theranostics · doi:10.7150/thno.70754 · Cited by 93
“FOXO3 inactivates FOXM1 directly and antagonizes FOXM1 function by competing for the same target genes [60].”
BackgroundMolecular Pathways: Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling
Conforti, F., Wang, Y., Rodríguez, J. A., Alberobello, A. T., Zhang, Y.-W., & Giaccone, G. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0408 · Cited by 89
“Cornforth AN, Davis JS, Khanifar E, Nastiuk KL, Krolewski JJ. FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells.”
BackgroundPhosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking
Jin, G., Zhang, Y., Cong, W., Wu, X., Wang, X., Wu, S., Wang, S., Zhou, W., Yuan, S., Gao, H., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2006483 · Cited by 87
Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications
Dong, Y. W., Yang, C., & Pan, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.626172 · Cited by 92
Zeng, Y.-B., Liang, X.-H., Zhang, G., Jiang, N., Zhang, T., Huang, J.-Y., Zhang, L., & Zeng, X. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0328-z · Cited by 85
“Phosphorylation of FOXO3a induces its nuclear export, and promotes FOXO3a degradation [19].”
FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles
Yang, Z. P., Jiang, S., Cheng, Y., Li, T. X., Hu, W., Ma, Z., Chen, F., & Yang, Y. (2017) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834017742576 · Cited by 85
Crosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch.
Imai, Y., Takahashi, A., Hanyu, A., Hori, S., Sato, S., Naka, K., Hirao, A., Ohtani, N., & Hara, E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.006 · Cited by 84
Garfield, D. A., Runcie, D. E., Babbitt, C. C., Haygood, R., Nielsen, W., & Wray, G. A. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001696 · Cited by 89
“Forkhead transcription factors have also been proposed to play a special role in fine-tuning gene expression [85].”
BackgroundEndothelial Cell Development and Its Application to Regenerative Medicine
Qiu, J., & Hirschi, K. K. (2019) · Circulation Research · doi:10.1161/circresaha.119.311405 · Cited by 89
Li, X., Wu, Q., Bu, M., Hu, L., Du, W. W., Jiao, C., Pan, H., Sdiri, M., Wu, N., Xie, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8608 · Cited by 91
“The activated Akt can then phosphorylate Foxo3 in the nucleus, which is degraded to block it in targeting its downstream genes and triggering cell death pathway [23, 24].”
BackgroundInfluentialPrognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis
Li, L., Yu, Q., Yu, Q., Li, L., & Wu, P. (2017) · Oncotarget · doi:10.18632/oncotarget.15764 · Cited by 84
“FOXM1 is also linked to angiogenesis, cellular senescence, DNA damage response, drug resistance, cancer stem cell renewal and differentiation of cancer [2].”
BackgroundFOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension
Bourgeois, A., Lambert, C., Habbout, K., Ranchoux, B., Paquet-Marceau, S., Trinh, I., Breuils‐Bonnet, S., Paradis, R., Nadeau, V., Paulin, R., et al. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1619-0 · Cited by 84
“exclusion of FOXOs and thus upregulation of FOXM1 [30].”
BackgroundGenomic influences on self-reported childhood maltreatment
Dalvie, S., Maihofer, A. X., Coleman, J. R. I., Bradley, B., Breen, G. D., Brick, L. A. D., Chen, C., Choi, K. W., Duncan, L. E., Guffanti, G., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0706-0 · Cited by 90
PARP1 promote autophagy in cardiomyocytes via modulating FoxO3a transcription
Wang, C., Xu, W., Zhang, Y., Zhang, F., & Huang, K. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1108-6 · Cited by 84
FOXC1, the new player in the cancer sandbox
Elian, F., Yan, E., & Walter, M. A. (2017) · Oncotarget · doi:10.18632/oncotarget.22742 · Cited by 84
“FOX transcription factors (TFs) have distinct roles in embryonic and adult development [12], and are connected to chromatin remodeling as well as nuclear delocalization [2, 11, 12].”
BackgroundInfluentialFOXOs in cancer immunity: Knowns and unknowns
Deng, Y., Wang, F., Hughes, T. L., & Yu, J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.01.005 · Cited by 90
Okino, Y., Machida, Y., Frankland-Searby, S., & Machida, Y. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.609834 · Cited by 81
“The BAP1-interacting proteins FoxK1 and FoxK2 are members of the Fox transcription factors, which are characterized by the forkhead DNA-binding domains (24, 25).”
BackgroundXie, C., Guo, Y., & Lou, S. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-06019-1 · Cited by 82
Frequent Derepression of the Mesenchymal Transcription Factor Gene FOXC1 in Acute Myeloid Leukemia
Somerville, T. D. D., Wiseman, D. H., Spencer, G. J., Huang, X., Lynch, J. T., Leong, H. S., Williams, E. L., Cheesman, E., & Somervaille, T. C. P. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.07.017 · Cited by 84
“Although diverse forkhead box transcription factors exhibit highly conserved central DNA binding forkhead domains, they have very different flanking and transactivation sequences (Lam et al., 2013).”
BackgroundInfluentialde Moraes, G. N., Bella, L., Zona, S., Burton, M. J., & Lam, E. W. ‐. (2016) · Current Drug Targets · doi:10.2174/1389450115666141122211549 · Cited by 86
“Forkhead Box M1 (FOXM1) transcription factor regulates a broad spectrum of normal biological functions, including cell proliferation, cell cycle progression, cell renewal, cell differentiation, DNA damage repair, tissue homeostasis, cell migration, angiogenesis and cell survival [60].”
BackgroundSelf-citationThe FoxO3 gene and cause‐specific mortality
Willcox, B. J., Tranah, G. J., Chen, R., Morris, B. J., Masaki, K., He, Q., Willcox, D. C., Allsopp, R., Moisyadi, S., Poon, L. W., et al. (2016) · Aging Cell · doi:10.1111/acel.12452 · Cited by 80
“Although FOXO3 is a tumor suppressor (Lam et al., 2013; Fruman & Rommel, 2014), we could find only one study that reported an association of FOXO3 genotype with all-cancer mortality (Pawlikowska et al.”
BackgroundFoxc1 and Foxc2 deletion causes abnormal lymphangiogenesis and correlates with ERK hyperactivation
Fatima, A., Wang, Y., Uchida, Y., Norden, P., Liu, T., Culver, A., Dietz, W. H., Culver, F., Millay, M., Mukouyama, Y.-S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80465 · Cited by 79
Fiskus, W. C., Coothankandaswamy, V., Chen, J., Ma, H., Ha, K., Saenz, D. T., Krieger, S., Mill, C. P., Sun, B., Huang, P., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0126 · Cited by 77
“FOXO3A and BIM involvement in increased cell death due to oxidative stress in SIRT2ovreexpressing breast cancer cells.”
BackgroundInfluentialAgeing as developmental decay: insights from p16INK4a.
Martin, N., Beach, D., & Gil, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.09.008 · Cited by 76
EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma
Cidre‐Aranaz, F., & Alonso, J. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00162 · Cited by 78
“FOX proteins regulate gene networks that are involved in cell cycle progression, proliferation, differentiation, metabolism, senescence, survival, or apoptosis (60).”
BackgroundAbdi, K., Lai, C.-H., Paez-Gonzalez, P., Lay, M., Pyun, J., & Kuo, C. T. (2018) · Nature Communications · doi:10.1038/s41467-018-03812-w · Cited by 74
Yi, J., Li, H., Chu, B., Kon, N., Hu, X., Hu, J., Xiong, Y., Kanıskan, H. Ü., Jin, J. J., & Gu, W. J. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01180-7 · Cited by 77
“Unlike other FOX family proteins, FOXM1 predominantly expresses in proliferating cells and overexpression of FOXM1 is a hallmark of various human cancers [16, 19].”
BackgroundInfluentialFOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10
Xie, T., Geng, J., Wang, Y., Wang, L., Huang, M., Chen, J., Zhang, K., Xue, L., Liu, X., Mao, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14351 · Cited by 70
“FOXM1 is a key transcription factor in cell cycle progression [6], DNA replication [7], angiogenesis [8], metastasis [9] and drug resistance [10], which belongs to a large Forkhead Box family that share a conserved winged-helix DNA-binding domain [11].”
Unfolded protein response in colorectal cancer
Huang, J., Pan, H., Wang, J., Wang, T., Huo, X., Ma, Y., Lu, Z., Sun, B., & Jiang, H. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00538-z · Cited by 72
Hill, R., Madureira, P. A., Ferreira, B. I., Baptista, I., Machado, S., Colaço, L., dos Santos, M., Liu, N., Dopazo, A., Ugurel, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms14687 · Cited by 73
RetractedJiang, Y., Zhang, H., Li, W., Yang, Y., Yao, X., & Gu, W. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00357-19 · Cited by 69
“Forkhead Box M1 (FOXM1), a member of the FOX protein family, is immensely important in cell cycle progression, mitosis, and tissue homeostasis (38, 39).”
BackgroundPositive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis
Porras, L., Ismail, H., & Mader, S. (2021) · Cells · doi:10.3390/cells10112966 · Cited by 77
FOXO3a-driven miRNA signatures suppresses VEGF-A/NRP1 signaling and breast cancer metastasis
Song, Y., Zeng, S., Zheng, G., Chen, D., Li, P., Yang, M., Luo, K., Yin, J., Gu, Y., Zhang, Z., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01562-y · Cited by 71
FOXK transcription factors: Regulation and critical role in cancer
Liu, Y., Ding, W., Ge, H., Ponnusamy, M., Wang, Q., Hao, X., Wu, W., Zhang, Y., Yu, W., Ao, X., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.030 · Cited by 69
Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple‐negative breast cancer
Yang, N., Wang, C., Wang, J., Wang, Z., Huang, D., Yan, M., Muhammad, K. I., Liu, Q., & Xu, B. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14538 · Cited by 70
Deciphering the roles of FOXO1 in human neoplasms
Jiang, S., Li, T. X., Yang, Z. P., Hu, W., & Yang, Y. (2018) · International Journal of Cancer · doi:10.1002/ijc.31338 · Cited by 66
UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1
Nicolau‐Neto, P., Palumbo, A., Martino, M. D., Esposito, F., Simão, T. D. A., Fusco, A., Nasciutti, L. E., Costa, N. M. D., & Pinto, L. F. R. (2018) · Genes · doi:10.3390/genes9040188 · Cited by 65
“Specifically, FOXM1 overexpression results in an increase of mitotic cell population and induces expression of a large set of G2/M genes [20].”
BackgroundInfluentialUpregulation of FoxP4 in HCC promotes migration and invasion through regulation of EMT
Zhang, G., & Zhang, G. (2019) · Oncology Letters · doi:10.3892/ol.2019.10049 · Cited by 67
Metadata
- Authors
- Lam, E. W.-F., Brosens, J. J., Gomes, A. R., & Koo, C.-Y.
- Affiliations
- Hammersmith Hospital (GB)
- University Hospital Coventry (GB)
- Corresponding author
- Lam, Eric W.-F.
- Venue
- Nature Reviews Cancer
- Published
- 2013-06-24
- Volume
- 13
- Issue
- 7
- Pages
- 482-495
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2076174368
- Cited by
- 684
- References
- 199
- Citations by year
- 2026: 20 · 2025: 45 · 2024: 52 · 2023: 65 · 2022: 67 · 2021: 70 · 2020: 57 · 2019: 64 · 2018: 56 · 2017: 56 · 2016: 51 · 2015: 53 · 2014: 24 · 2013: 2
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research UK (12011)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- forkhead transcription factor, FoxA, FOXO, FoxP, gene expression regulation, cancer, therapeutic target, biomarkers, drug resistance, signal integration
- MeSH terms
- Antineoplastic Agents, Humans, Neoplasms, Forkhead Transcription Factors, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.